-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Elicio Therapeutics, Raises Price Target to $17

Benzinga·03/13/2026 11:16:40
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Elicio Therapeutics (NASDAQ:ELTX) with a Buy and raises the price target from $13 to $17.